Monitoring of methotrexate levels following glucarpidase rescue treatment requires detection by mass spectrometry since immunoassay is not applicable

Abstract

BackgroundPatients treated with high-dose methotrexate may experience severe toxicity when excretion is delayed if acute renal dysfunction develops. Potentially lethal toxicity may be limited by hydration, alkalisation and administration of...